ISMPP Highlights
Translations & Presentations of Joint Position Statement Advocating for Pre-Publication Review
AMWA, EMWA, and ISMPP announce the availability of translations into Chinese, Japanese, and Spanish of their Joint Position Statement on Medical Publications, Preprints, and Peer Review, published in CMRO in March 2021. Upcoming presentations in various global regions are also underway…
2021 Member Research, FDA Action for Failure to Submit Clinical Trial Results for Posting, Guideline Updates
Learn from the scientific posters presented at the 2021 European Meeting of ISMPP in January and the 17th Annual Meeting of ISMPP in April. Find out about the first US FDA Notice of Noncompliance for failure to post clinical trial results on ClinicalTrials.gov, as well as an updated PRISMA Statement and a new CONSORT Extension…
An Exceptional 17th Annual Meeting Sets Attendance Record!
In what has been a unique year with facing the COVID-19 pandemic, changing practices for medical publications and communications, and adjusting to work from home and virtual congresses, ISMPP was especially thrilled to have over 650 attendees participate in our virtual 17th Annual Meeting, setting a NEW ATTENDANCE RECORD!…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
Change as the Only Constant: How Will the Role of Medical Communication Professionals Evolve by 2025?
As the medical communications field rapidly evolves, the scale and scope of our profession are expanding. What are the areas that publication professionals need to learn about and what skills will be needed to be successful in 2025?…
The Year in Review / The Year Ahead
“The Year in Review / The Year Ahead” highlights significant topics in the year 2020 that were selected by The MAP Working Group. Watch three members of The MAP Working Group introduce each topic in videos. Information is also provided about ISMPP resources covering the individual topics…
What I Would Like You to Know: A Medical Affairs Perspective
What are the key things you want your medical publication colleagues to know from your experience as a medical affairs professional? It is key to think strategically when working in the medical affairs profession. Developing a publication is not just creating a data dump from the clinical study report; it is telling a story out of that data…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
POLL RESULTS: Adverse Event Inclusion Just Before Abstract Submission
A medical writer worked with authors to develop a congress abstract for a Phase 2 clinical study. Two days before submission, the lead author requests an additional ‘medical narrative’ statement to be added detailing the management steps and time to resolution of an adverse event seen in one patient. What would you do?
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals